1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Post-COVID-19 Condition: new trials by email Literature Review of Post-COVID-19 Condition trials Research Report on Post-COVID-19 Condition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vortioxetine for Post-COVID-19 Condition Vortioxetine, Placebo - Post-COVID-19 Condition, Post-COVID-19 Syndrome | Phase 2 | Completed | Brain and Cognition Discovery Foundation | 149 | 2021-09-16 | 2025-01-16 |
Cognition Disorders (1) · Cognitive Dysfunction (1) · Fatigue (1) · Mental Fatigue (1) · Post-Acute COVID-19 Syndrome (1)
Behavior (1) · Behavioral Symptoms (1) · COVID-19 (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Infections (1) · Lung Diseases (1) · Mental Disorders (1) · Neurocognitive Disorders (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1)
Vortioxetine (1)
Brain and Cognition Discovery Foundation (1)
Canada (1)
Roger S. McIntyre, MD, FRCPC (1)
PMID 38114867, PMID 38424537, PMID 38520501, PMID 38860901, PMID 38954402